OTCPK:BIOYF (Canada)  
Biosyent Inc logo

Biosyent Inc

$ 5.27 -0.05 (-0.94%) 10:08 PM EST
P/E:
14.02
P/B:
2.65
Market Cap:
$ 64.83M
Enterprise V:
$ 45.75M
Volume:
2.20K
Avg Vol (2M):
11.14K
Also Trade In:
Volume:
2.20K
Market Cap $:
64.83M
PE Ratio:
14.02
Avg Vol (2-Month):
11.14K
Enterprise Value $:
45.75M
PB Ratio:
2.65
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Biosyent Inc is a growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical and other healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn and Tibella.

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with OTCPK:BIOYF

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 21.471
EPS (TTM) ($) 0.376
Beta 0.9
Volatility % 21.85
14-Day RSI 44.96
14-Day ATR ($) 0.108506
20-Day SMA ($) 5.388457
12-1 Month Momentum % -23.66
52-Week Range ($) 4.69 - 7.925
Shares Outstanding (Mil) 12.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Biosyent Inc Filings

Document Form Filing Date
No Filing Data

Biosyent Inc Analysis

Share your research

Headlines

See More
No news.